Desktop Genetics

📍 Cambridge, United States🗓 Founded 2012💰 Last funded Dec 2015
Biotechnology🌐 deskgen.com
Website LinkedIn
Desktop Genetics is an international company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library product range, which enables the work of our pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics'​ tools and technologies are used by over 1800 organisations all over the world, and our projects contribute directly to several key partnerships to bring CRISPR into the clinic.
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2012
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
2
United States
1
Frequently asked questions
Who invested in Desktop Genetics?
Desktop Genetics has 3 investors on record on gritt.io, 3 mid-stage.
When did Desktop Genetics last raise funding?
The most recent investment in Desktop Genetics recorded on gritt.io was in December 2015.
When was Desktop Genetics founded?
Desktop Genetics was founded in 2012.
What industry is Desktop Genetics in?
Desktop Genetics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Desktop Genetics based?
Desktop Genetics is headquartered in Cambridge, United States.